Skip to content
Back to CNTB

Connect Biopharma Holdings Ltd

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
2
Purchases
2
Sales
0
Purchase value
$4.37M
Sale value
$0.00

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

James HuangDirector
4
Filed Jun 2, 2026Period of report May 29, 20260001193125-26-253607
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseMay 29, 2026
Ordinary SharesF1F2150,000$2.4774$371.61K13,310,000IndirectSee Footnote
Filing footnotes · 2
  1. F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $2.37 to $2.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
  2. F2Panacea Venture Healthcare Fund II, L.P. is the record holder of the Ordinary Shares reported herein. James Huang is the sole owner of Panacea Innovation Limited, which is the sole owner of Panacea Venture Healthcare Fund II GP Company, Ltd., which is the general partner of Panacea Venture Healthcare Fund II, L.P. As a result, James Huang may be deemed to share beneficial ownership of the Ordinary Shares reported herein, but disclaims such beneficial ownership.
Open on SEC EDGAR
James HuangDirector
4
Filed Apr 1, 2026Period of report Mar 31, 20260001193125-26-138012
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseMar 31, 2026
Ordinary SharesF11,160,000$3.45$4.00M13,160,000IndirectSee Footnote
Filing footnotes · 1
  1. F1Panacea Venture Healthcare Fund II, L.P. is the record holder of the Ordinary Shares reported herein. James Huang is the sole owner of Panacea Innovation Limited, which is the sole owner of Panacea Venture Healthcare Fund II GP Company, Ltd., which is the general partner of Panacea Venture Healthcare Fund II, L.P. As a result, James Huang may be deemed to share beneficial ownership of the Ordinary Shares reported herein, but disclaims such beneficial ownership.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.